The optimized semaglutide-loaded DPI, composed of semaglutide, mannitol, coarse lactose, fine lactose, and magnesium stearate at a weight ratio of 0.71:2.0:2.203:0.55:0.037, achieved a fine particle mass (FPM) of 36.9% of the total semaglutide, representing the fraction of particles with an aerodynamic diameter smaller than 5 m suitable for deep lung deposition
Favorable reimbursement coverage across developed markets and strong commercial penetration have supported widespread adoption
To be eligible, you must: Have a BMI of 40 or above , or 37.5 or above if you are from a minority ethnic background AND, Have four out of five of the following: Type 2 diabetes High blood pressure High cholesterol Sleep problems (like sleep apnoea) Heart disease Important Notes GLP-1 medicines are not magic
Abbreviations DPP-4: Dipeptidyl peptidase-4 EMA: European Medicines Agency EPAC: Exchange protein directly activated by cAMP FDA: Food and Drug Administration FGF21: Fibroblast growth factor 21 GIP: Glucose-dependent insulinotropic polypeptide GLP-1: Glucagon-like peptide-1 PKA: Protein kinase A SGLT-2: Sodiumglucose cotransporter 2 References Moore B, Edie ES, Abram JS (1906) On the treatment of diabetes mellitus by acid extract of duodenal mucous membrane
Lancet 368(9548):16961705 Muskiet MHA, Tonneijck L, Smits MM, Van Baar MJB, Kramer MHH, Hoorn EJ et al (2017) GLP-1 and the kidney: From physiology to pharmacology and outcomes in diabetes
Dietary changes and/or the taking of nutritional supplements may have differing effects on individuals
